结直肠癌
免疫
重编程
表观遗传学
免疫系统
免疫学
医学
佐剂
癌症研究
外周血单个核细胞
先天免疫系统
获得性免疫系统
效应器
生物
癌症免疫疗法
细胞免疫
抗原
免疫疗法
癌症
接种疫苗
癌细胞
巨噬细胞
细胞毒性T细胞
作者
Firas Hamdan,Sara Gandolfi,Federica D’Alessio,Yvonne Giannoula,Julia Kolikova,Manlio Fusciello,Elisa Zaghen,Alessandra Napolano,Salvatore Russo,Ozan Izci,Paolo Bottega,Jacopo Chiaro,Kirsi-Marja Alanen,Gabriella Antignani,Michaela Feodoroff,Virpi Stigzelius,Migle Sakalauskaite,Janita Sandberg,Anni I. Nieminen,Nicola Zambrano
标识
DOI:10.1038/s41467-026-68466-5
摘要
Colorectal cancer (CRC) remains refractory to most immunotherapies, with cancer vaccines failing due to an immunosuppressive tumor microenvironment. Here, we show that β-glucan–induced trained immunity overcomes these barriers by reprogramming macrophages through H3K4me3-dependent epigenetic modifications and metabolic rewiring. In female mice vaccinated with peptide-coated adenovirus-based vaccine PeptiCrad, training enhances glycolysis with creatine metabolism sustaining CXCL9/10 production, enabling macrophages to recruit NK cells via CXCR3. In turn, NK cells produce CCL5, driving cDC1 infiltration and antigen presentation, which together amplify effector memory CD8⁺ T cell responses. Moreover, with human peripheral blood mononuclear cells and CRC patient-derived organoids, trained macrophages boost NK migration, antigen-specific T cell activation, and tumor killing. These findings highlight trained immunity as a powerful adjuvant to reinvigorate colorectal cancer vaccination. Beta-glucan is an inducer of trained immunity, an epigenetic and metabolic reprogramming of the innate immune cells conferring immunological memory. Here the authors show that glucan-induced trained immunity enhances response to a cancer vaccine platform in colorectal cancer models, by inducing epigenetic and metabolic rewiring of macrophages that promotes an NK-cDC1 axis boosting anti-tumor immunity.
科研通智能强力驱动
Strongly Powered by AbleSci AI